Funder
Natural Science Foundation of Hubei Province
Subject
Toxicology,General Medicine,Food Science
Reference34 articles.
1. MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer;Abdallah;Int. J. Cancer,2016
2. Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy;Atasilp;Sci. Rep.,2020
3. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: application to a pharmacokinetic study of irinotecan in rats;Basu;J. Chromatogr., B: Anal. Technol. Biomed. Life Sci.,2016
4. New ABCC2 rs3740066 and rs2273697 polymorphisms identified in a healthy Colombian cohort;Bustos-Cruz;Pharmaceutics,2018
5. ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients;Chen;Pharmacogenetics Genom.,2015